| Basics |
Bio-Rad Laboratories, Inc.Class A
Bio-Rad Laboratories Inc manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a products and systems used to separate complex chemical and biological materials.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$6.64B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.55 | 1.13%
|
| Avg Daily Range (30 D): |
$5.41 | 2.28%
|
| Avg Daily Range (90 D): |
$5.09 | 1.81%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.11M |
| Avg Daily Volume (30 D): |
.3M |
| Avg Daily Volume (90 D): |
.22M |
| Trade Size |
| Avg Trade Size (Sh.): |
53 |
| Avg Trade Size (Sh.) (30 D): |
30 |
| Avg Trade Size (Sh.) (90 D): |
29 |
| Institutional Trades |
| Total Inst.Trades: |
4,001 |
| Avg Inst. Trade: |
$9.02M |
| Avg Inst. Trade (30 D): |
$14.61M |
| Avg Inst. Trade (90 D): |
$11.05M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$11.25M |
| Avg Closing Trade (30 D): |
$16.66M |
| Avg Closing Trade (90 D): |
$11.56M |
| Avg Closing Volume: |
31.6K |
|
|
|
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-27.74
|
$23.37
|
$-76.26
|
|
Diluted EPS
|
$-27.75
|
$23.34
|
$-76.26
|
|
Revenue
|
$ 2.58B
|
$ 649.73M
|
$ 638.48M
|
|
Gross Profit
|
$ 1.4B
|
$ 355.9M
|
$ 355.12M
|
|
Net Income / Loss
|
$ -778.7M
|
$ 653.17M
|
$ -2165.49M
|
|
Operating Income / Loss
|
$ 305.99M
|
$ 64.47M
|
$ 101.5M
|
|
Cost of Revenue
|
$ 1.18B
|
$ 293.83M
|
$ 283.36M
|
|
Net Cash Flow
|
$ -46.45M
|
$ 4.47M
|
$ -26.04M
|
|
PE Ratio
|
|
|
|
|
